TBX3 and cancer: Niclosamide, piroctone olamine, and pyrvinium pamoate have been shown to exhibit anti‐cancer activity through their ability to inhibit signalling pathways such as the WNT/B‐catenin that can transcriptionally activate TBX2/TBX3 [28, 29, 30].